TABLE 2.
Patient group (n) | No. of mutations observed
|
||||||
---|---|---|---|---|---|---|---|
D30N | M46I/L | G48V | I50V | V82A/T/S/F | I84V/A | L90M | |
PI treated (30) | 1 | 4 | 0 | 0 | 2 | 2 | 13 |
PI untreated (25) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Patient group (n) | No. of mutations observed
|
||||||
---|---|---|---|---|---|---|---|
D30N | M46I/L | G48V | I50V | V82A/T/S/F | I84V/A | L90M | |
PI treated (30) | 1 | 4 | 0 | 0 | 2 | 2 | 13 |
PI untreated (25) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |